Clinical Trials on Bardet Biedl Syndrome (BBS) in Japan
Total 9 results
-
Astellas Pharma IncCompletedConstipation-predominant Irritable Bowel Syndrome (IBS-C)Japan
-
Nihon Pharmaceutical Co., LtdCompletedGuillain-Barré SyndromeJapan
-
Japan Blood Products OrganizationCompleted
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C)Japan
-
Chiba UniversityJapan Agency for Medical Research and DevelopmentCompleted
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C) | Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)Japan
-
Alexion Pharmaceuticals, Inc.CompletedGuillain-Barre SyndromeJapan
-
Chugai PharmaceuticalNot yet recruitingAntiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)United States, Japan
-
Erasmus Medical CenterActive, not recruitingGuillain-Barré Syndrome | Miller Fisher SyndromeUnited States, Netherlands, United Kingdom, Bangladesh, Australia, Denmark, China, France, Germany, Spain, Argentina, Italy, Puerto Rico, South Africa, Belgium, Switzerland, Canada, Greece, Japan, Malaysia, Taiwan